5501
Amr Omaia Ahmed Salah El Deen
Evaluation Of Glypican 3 As A Tumour Marker For Early Diagnosis Of Hepatocellular Carcinoma
Glypican 3 ,Hepatocellular Carcinoma
Evaluation of the serum marker Glypican3 in Egyptian patients with HCC, in comparison to other patients with HCV/HBV related liver cirrhosis. • Comparing the level of the studied serological marker (Glypican3) to AFP to determine its clinical significance in the non-invasive early detection of hepatocellular carcinoma.
2015
M.D
Cairo
Medicine